Ever Bilena
Ever Bilena Eye Liner
Eye liner
2
Bien
21
Neutre
0
Mise en garde
1
Éviter
8% bien
88% neutre
0% mise en garde
4% éviter
À propos du produit
- Marque
- Ever Bilena
- Ingrédients
- 24
- Actifs
- 1
Survolez une ligne · cliquez pour la carte
Isononyl Isononanoate
antistatic emollient skin conditioning
→
Polyethylene
Octyldodecanol
emollient masking perfuming
→
Silica
abrasive absorbent anticaking bulking opacifying viscosity controlling
→
Dimethicone
Euphorbia Cerifera Cera
astringent emulsion stabilising film forming perfuming skin conditioning viscosity controlling
→
Polyisobutene
binding film forming viscosity controlling
→
Caprylyl Methicone
skin conditioning
→
Microcrystalline Wax
binding bulking emulsion stabilising viscosity controlling
→
Polyhydroxystearic Acid
emulsifying
→
C30-45 Alkyl Cetearyl Dimethicone Crosspolymer
emollient film forming hair conditioning skin conditioning
→
Lecithin
antistatic emollient emulsifying skin conditioning
→
Tocopherol
Vitamin E
antioxidant masking skin conditioning
→
Ascorbyl Palmitate
Form of Vitamin C
antioxidant masking
→
Glyceryl Stearate
emollient emulsifying
→
Glyceryl Oleate
emollient emulsifying perfuming
→
Citric Acid
buffering chelating masking
→
Ci 77499
Iron Oxide Black
cosmetic colorant
→
Ci 77491
Iron Oxide Red
cosmetic colorant
→
Ci 77891
Titanium Dioxide/Ci 77891
cosmetic colorant
→
Ci 77492
Iron Oxide Yellow
cosmetic colorant
→
Ci 16035
Red 40
cosmetic colorant
→
Ci 45410
Red 28, Red 27, Red 27 Lake, Red 28 Lake, Acid Red 92 Phloxine
cosmetic colorant
→
Carbon Black
Ci 77266
cosmetic colorant
→
Состав
Isononyl Isononanoate, Polyethylene, Octyldodecanol, Silica, Dimethicone, Euphorbia Cerifera Cera, Polyisobutene, Caprylyl Methicone, Microcrystalline Wax, Polyhydroxystearic Acid, C30-45 Alkyl Cetearyl Dimethicone Crosspolymer, Lecithin, Tocopherol, Ascorbyl Palmitate, Glyceryl Stearate, Glyceryl Oleate, Citric Acid, Ci 77499, Ci 77491, Ci 77891, Ci 77492, Ci 16035, Ci 45410, Carbon Black
Trouver des produits similaires…
L'historique des modifications n'est pas encore suivi